1 – 10 of 167
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Transcriptome-Wide Association Analysis Identifies Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
2024) In Human Genetics and Genomics Advances(
- Contribution to journal › Article
-
Mark
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
2024) In European Urology(
- Contribution to journal › Article
-
Mark
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI : The ProScreen Randomized Trial
(
- Contribution to journal › Article
-
Mark
Eight Misconceptions about Prostate-Specific Antigen
(
- Contribution to journal › Article
- 2023
-
Mark
Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
2023) p.1-36(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Genetically adjusted PSA levels for prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
(
- Contribution to journal › Article